Skip to content
Publicly Available Published by De Gruyter February 12, 2020

Corrigendum to: Pediatric reference intervals for 29 Ortho VITROS 5600 immunoassays using the CALIPER cohort of healthy children and adolescents

Victoria Higgins, Angela W.S. Fung, Man Khun Chan, Joseph Macri and Khosrow Adeli
This erratum corrects the original online version which can be found here: https://doi.org/10.1515/cclm-2017-0349

Corrigendum to: Higgins V, Fung AWS, Chan MK, Macri J, Adeli K. Pediatric reference intervals for 29 Ortho VITROS 5600 immunoassays using the CALIPER cohort of healthy children and adolescents. Clinical Chemistry and Laboratory Medicine 2018; volume 56, Issue 2, pp. 327–340. (DOI: https://doi.org/10.1515/cclm-2017-0349).

  1. Table 1 (SI units) in the original article contains incorrect values for the progesterone reference interval for males aged 15 to <19 years. Corrected progesterone reference intervals are provided below in the corrected Table 1 (SI Units).

  2. Supplementary Table 2 (CON units) in the original article therefore also contains incorrect values for the progesterone reference interval for males aged 15 to <19 years. Additionally, the upper progesterone reference limit for 11 to <15 years, the female progesterone 15 to <19 years sample size, the TSH reference interval for 0 to <1 week, and the iPTH reference intervals contained errors. Corrected reference intervals are provided below in the corrected Supplementary Table 2 (CON units).

  3. While labeled as μg/L, the y-axis values for Troponin I in Figure 7A were displayed as ng/L. The correct y-axis is shown in the corrected Figure 7A below:

Corrected Table 1 (SI units).

Analyte Female reference intervals
Male reference intervals
Age Lower limit Upper limit n Lower 90% confidence interval Upper 90% confidence interval Age Lower limit Upper limit n Lower 90% confidence interval Upper 90% confidence interval
Progesterone, nmol/L 0 to <2 weeks 7.9 >178 60 (2.5, 15) NA 0 to <2 weeks 7.9 >178 60 (2.5, 15) NA
2 weeks to –<11 years 0.49 12 312 (0.47, 0.57) (6.6, 17) 2 weeks to <11 years 0.49 12 312 (0.47, 0.57) (6.6, 17)
11 to <15 years 1.1 13 138 (1.0, 1.5) (7.8, 15) 11 to <15 years 1.1 13 138 (1.0, 1.5) (7.8, 15)
15 to <19 years 2.3 31.0 79 (2.2, 2.5) (12, 33) 15 to <19 years 2.8 9.1 79 (2.5, 3.0) (8.4, 9.8)

Corrected Supplementary Table 2 (CON units).

Analyte Female reference intervals
Male reference intervals
Age Lower limit Upper limit n Lower 90% confidence interval Upper 90% confidence interval Age Lower limit Upper limit n Lower 90% confidence interval Upper 90% confidence interval
Progesterone, nmol/L 0 to <2 weeks 2.50 >56 60 (0.78, 4.83) NA 0 to <2 weeks 2.50 >56 60 (0.78, 4.80) NA
2 weeks to <11 years 0.15 3.8 312 (0.15, 0.18) (2.1, 5.4) 2 weeks to <11 years 0.15 3.8 312 (0.15, 0.18) (2.1, 5.4)
11 to <15 years 0.35 4.09 138 (0.32, 0.48) (2.5, 4.6) 11 to <15 years 0.35 4.09 138 (0.32, 0.48) (2.5, 4.6)
15 to <19 years 0.73 9.8 79 (0.69, 0.79) (8.1, 12) 15 to <19 years 0.88 2.9 79 (0.79, 0.94) (2.6, 3.1)
iPTH, pg/mL 0 to <2 weeks 5.38 108 45 (4.43, 7.45) (87.7, 124) 0 to <2 weeks 5.38 108 45 (4.43, 7.45) (87.7, 124)
2 weeks to <9 years 11.6 67.4 203 (10.4, 13.5) (60.7, 75.1) 2 weeks to <9 years 11.6 67.4 203 (10.4, 13.5) (60.7, 75.1)
9 to <15 years 17.9 122 269 (16.2, 18.3) (95.2, 131) 9 to <15 years 17.9 122 269 (16.2, 18.3) (95.2, 131)
15 to <19 years 13.6 62.9 84 (12.3, 15.7) (53.2, 70.6) 15 to <19 yrs 15.7 79.3 82 (14.3, 16.7) (71.7, 86.6)
TSH, μIU/mL 0 to <1 week 0.71 31.5 51 (0.31, 1.40) (25.9, 37.5) 0 to <1 week 0.71 31.5 51 (0.31, 1.40) (25.9, 37.5)
1 week to <19 years 0.86 5.70 600 (0.77, 0.94) (5.37, 6.28) 1 week to <19 years 0.86 5.70 600 (0.77, 0.94) (5.37, 6.28)
Figure 7A.  

Figure 7A.

Published Online: 2020-02-12
Published in Print: 2020-03-26

©2020 Walter de Gruyter GmbH, Berlin/Boston

Scroll Up Arrow